The Central Role of Angiotensin I-Converting Enzyme in Vertebrate Pathophysiology
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
1431-1452
Author(s):
David W. Moskowitz and Frank E. Johnson
The Anandamide Degradation System as Potential Target for the Treatment of Central Nervous System Related Disorders
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
4
Page:
155-160
Author(s):
Maria L Lopez-Rodriguez and Silvia Ortega-Gutierrez
AKT: A Potential Target for Thyroid Cancer Therapy
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
181-185
Author(s):
Faiza Kada, Motoyasu Saji and Matthew D. Ringel
Dendritic Cell-Based Immunotherapy in Thyroid Malignancies
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
245-251
Author(s):
Matthias Schott, Werner A. Scherbaum and Jochen Seissler
Telomerase as Drug and Drug Target for the Treatment of Thyroid Cancer
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
253-256
Author(s):
M. A. Zeiger and A. K. Meeker
Chromogranin A in Tumors: More Than a Marker for Diagnosis and Prognosis
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
4
Page:
161-168
Author(s):
Angelo Corti and Elisabetta Ferrero
Antifolates - Past, Present and Future
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
405-410
Author(s):
Aleem Gangjee and Hiteshkumar D. Jain
Monoclonal Antibodies in Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
411-414
Author(s):
Barbara Gatto
Anticancer Agents: Towards the Future
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
425-427
Author(s):
Manlio Palumbo
Optimizing Target Selection and Development Strategy in Cancer Treatment; The Next Wave
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
445-447
Author(s):
Edward A. Sausville